| Quarterly Financials | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 434 | 424 | 626 | 834 | 524 | 452 | 650 | 908 | 566 | 539 | 787 | 918 | 713 | 672 | 991 | 1,131 | 766 | 668 | 742 | 928 | 569 | 701 | 865 | 1,020 | 673 |
| Expenses | 414 | 396 | 541 | 674 | 503 | 407 | 529 | 683 | 483 | 463 | 632 | 696 | 581 | 556 | 798 | 843 | 633 | 571 | 644 | 716 | 476 | 534 | 678 | 743 | 536 |
| EBITDA | 20 | 27 | 85 | 160 | 22 | 46 | 121 | 225 | 84 | 76 | 155 | 223 | 133 | 116 | 192 | 289 | 134 | 97 | 98 | 213 | 93 | 167 | 187 | 277 | 137 |
| Operating Profit % | 4 % | 6 % | 13 % | 19 % | 4 % | 9 % | 18 % | 24 % | 14 % | 13 % | 19 % | 24 % | 18 % | 16 % | 19 % | 25 % | 16 % | 12 % | 11 % | 21 % | 12 % | 21 % | 19 % | 25 % | 17 % |
| Depreciation | 7 | 7 | 9 | 9 | 10 | 13 | 11 | 11 | 11 | 14 | 11 | 11 | 11 | 11 | 11 | 15 | 11 | 14 | 14 | 16 | 16 | 17 | 15 | 16 | 19 |
| Interest | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 13 | 18 | 75 | 150 | 11 | 32 | 109 | 212 | 71 | 61 | 142 | 210 | 120 | 104 | 180 | 272 | 121 | 82 | 83 | 196 | 75 | 149 | 171 | 260 | 117 |
| Tax | 11 | 19 | 21 | 22 | 10 | 9 | 30 | 54 | 17 | 7 | 37 | 55 | 31 | 30 | 42 | 71 | 30 | 10 | 22 | 52 | 21 | 39 | 44 | 67 | 29 |
| Net Profit | 2 | -1 | 53 | 128 | 1 | 23 | 79 | 158 | 54 | 54 | 106 | 154 | 89 | 75 | 138 | 202 | 91 | 72 | 62 | 143 | 55 | 110 | 127 | 193 | 87 |
| EPS in ₹ | 0.03 | -0.02 | 1.07 | 2.56 | 0.01 | 0.46 | 1.59 | 3.16 | 1.08 | 1.08 | 2.12 | 3.09 | 1.78 | 1.50 | 2.77 | 4.04 | 1.81 | 1.45 | 1.24 | 2.87 | 1.10 | 2.20 | 2.54 | 3.85 | 1.74 |
Sumitomo Chemical
549.60
+19.25
(3.63%)
Market Cap
27,433.05 Cr
EPS
7.40
PE Ratio
51.24
Dividend Yield
1.11 %
Industry
Chemicals52 Week High
628.30
52 Week Low
341.80
PB Ratio
9.74
Debt to Equity
0.01
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from7 analysts
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,430.60 | #1 52,048.42 | 31.16 | 7,873.50 | #1 18.38 | #1 1,682 | -16.92 | 60.51 | |
632.45 | 47,474.29 | - | #1 43,581.00 | -19.37 | -1,878 | 153.08 | 62.99 | |
4,927.00 | 22,142.97 | 40.73 | 5,184.20 | -0.37 | 741 | -63.27 | 42.18 | |
1,272.70 | 5,737.12 | #1 21.06 | 1,793.50 | 2.78 | 239 | 21.15 | 52.13 | |
577.50 | 5,210.23 | 22.33 | 3,222.80 | -21.11 | 32 | #1 576.09 | 59.63 | |
10,490.00 | 4,358.88 | 24.12 | 1,065.50 | -15.01 | 96 | 164.71 | 55.25 | |
217.38 | 4,227.36 | 31.33 | 2,631.40 | 6.54 | 164 | -274.07 | 47.40 | |
278.70 | 3,613.88 | 167.63 | 410.30 | -18.49 | 18 | 9.09 | 40.77 | |
102.43 | 2,042.86 | - | 1,787.30 | -15.91 | -59 | -127.67 | 66.27 | |
Sumitomo Chemical this company | 549.60 | #3 27,433.05 | #7 51.24 | #5 2,939.60 | #7 -17.33 | #3 370 | #4 59.78 | 62.84 |
Growth Rate
Revenue Growth
-17.33 %
Net Income Growth
-26.38 %
Cash Flow Change
94.45 %
ROE
-28.26 %
ROCE
-25.33 %
EBITDA Margin (Avg.)
-3.05 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,658 | 1,860 | 2,106 | 2,672 | 3,010 | 3,369 | 3,313 |
| Fixed Assets | 267 | 279 | 320 | 309 | 390 | 430 | 563 |
| Current Assets | 1,346 | 1,542 | 1,746 | 2,304 | 2,522 | 2,788 | 2,673 |
| Capital Work in Progress | 9 | 8 | 10 | 14 | 35 | 71 | 23 |
| Investments | 0 | 0 | 86 | 290 | 356 | 239 | 346 |
| Other Assets | 1,383 | 1,573 | 1,690 | 2,058 | 2,228 | 2,629 | 2,382 |
| Total Liabilities | 1,658 | 1,860 | 2,106 | 2,672 | 3,010 | 3,369 | 3,313 |
| Current Liabilities | 672 | 781 | 840 | 1,081 | 1,021 | 933 | 801 |
| Non Current Liabilities | 33 | 30 | 45 | 50 | 61 | 54 | 68 |
| Total Equity | 954 | 1,048 | 1,222 | 1,541 | 1,927 | 2,382 | 2,445 |
| Reserve & Surplus | 679 | 549 | 723 | 1,042 | 1,428 | 1,883 | 1,942 |
| Share Capital | 275 | 275 | 499 | 499 | 499 | 499 | 499 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 15 | -23 | 42 | 96 | -131 | -10 | -0 |
| Investing Activities | -40 | -35 | -118 | -283 | -290 | -327 | -420 |
| Operating Activities | 47 | 78 | 221 | 425 | 222 | 389 | 757 |
| Financing Activities | 7 | -65 | -61 | -47 | -63 | -73 | -337 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 2.75 % | 3.07 % | 3.49 % | 3.59 % |
| DIIs | 6.28 % | 6.57 % | 6.12 % | 6.17 % | 6.35 % | 6.56 % | 6.20 % | 5.52 % | 5.51 % | 5.08 % | 5.64 % | 5.72 % | 6.64 % | 7.14 % | 6.97 % | 6.96 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 12.25 % | 12.13 % | 12.65 % | 12.70 % | 12.28 % | 11.92 % | 11.99 % | 12.06 % | 11.86 % | 11.92 % | 11.50 % | 11.49 % | 11.41 % | 10.75 % | 10.39 % | 10.31 % |
| Others | 6.48 % | 6.30 % | 6.22 % | 6.13 % | 6.37 % | 6.51 % | 6.81 % | 7.42 % | 7.63 % | 8.00 % | 7.86 % | 7.79 % | 4.20 % | 4.04 % | 4.15 % | 4.14 % |
| No of Share Holders | 0 | 73,327 | 78,651 | 1,19,561 | 1,50,589 | 1,39,601 | 1,33,658 | 1,46,063 | 1,42,596 | 1,56,136 | 1,47,907 | 1,45,083 | 1,48,764 | 1,28,148 | 1,24,857 | 1,25,812 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 2.29 | 0.75 | 0.8 | 1 | 1.2 | 5.9 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 1.24 | 0.26 | 0.18 | 0.24 | 0.35 | 1.11 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Integrated Filing (Financial)
Mar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Credit RatingFeb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJan 27, 2025
Jan 27, 2025Financial Results For The Quarter And Nine Months Ended 31St December 2024Jan 27, 2025
Jan 27, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Board Meeting Intimation for Schedule Of Board Meeting To Be Held On 27Th January 2025.Jan 06, 2025
Jan 06, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 12, 2024
Dec 12, 2024Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Compounding Of Offence Under Legal Metrology Act, 2009 And Rules Made Thereunder.Nov 29, 2024
Nov 29, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 27, 2024
Nov 27, 2024Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Nov 22, 2024
Nov 22, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 20, 2024
Nov 20, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 13, 2024
Nov 13, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2024
Nov 12, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 05, 2024
Nov 05, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 29, 2024
Oct 29, 2024Investor Presentation On Financial Results For The Quarter And Half Year Ended 30.09.2024Oct 29, 2024
Oct 29, 2024Financial Results For The Quarter And Half Year Ended 30.09.2024Oct 28, 2024
Oct 28, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 21, 2024
Oct 21, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 11, 2024
Oct 11, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Oct 10, 2024Board Meeting Intimation for Considering Inter-Alia The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended 30Th September, 2024.Oct 07, 2024
Oct 07, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 25, 2024
Sep 25, 2024Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Sep 20, 2024
Sep 20, 2024Query Raised By BSE For Additional Details On Appointment Of Statutory Auditor Of The Company.Sep 03, 2024
Sep 03, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 30, 2024
Aug 30, 2024Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Aug 29, 2024
Aug 29, 2024Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Aug 28, 2024
Aug 28, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2024
Aug 28, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateAug 27, 2024
Aug 27, 2024Disclosure About Reappointment/Appointment Of Independent Directors.Jul 31, 2024
Jul 31, 2024Promotion Of Dr. Suresh Ramachandran (Whole-Time Director) To The Position Of Deputy Managing Director.Jul 31, 2024
Jul 31, 2024Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sJul 31, 2024
Jul 31, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportJul 31, 2024
Jul 31, 2024Proceedings Of The 24Th Annual General Meeting.Jul 30, 2024
Jul 30, 2024Announcement under Regulation 30 (LODR)-Investor PresentationJul 27, 2024
Jul 27, 2024Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June, 2024.Jul 27, 2024
Jul 27, 2024Board Meeting Outcome for Unaudited Financial Results (Standalone And Consolidate) For The Quarter Ended 30Th June, 2024.Jul 27, 2024
Jul 27, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Jul 11, 2024Business Responsibility and Sustainability Reporting (BRSR)Jul 09, 2024
Jul 09, 2024Board Meeting Intimation for Board Meeting To Be Held On Saturday, 27Th July, 2024 To Consider Inter-Alia The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2024.Jul 03, 2024
Jul 03, 2024Record Date For Ascertaining Eligibility Of Shareholders For Payment Of Final Dividend For F.Y. 2023-24Jul 01, 2024
Jul 01, 2024Reg. 34 (1) Annual Report.Jun 29, 2024
Jun 29, 2024Reg. 34 (1) Annual Report.Jun 29, 2024
Jun 29, 2024Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 03, 2024
Jun 03, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 28, 2024
May 28, 2024Announcement under Regulation 30 (LODR)-Investor PresentationMay 28, 2024
May 28, 2024Financial Results For The Year Ended 31.03.2024May 27, 2024
May 27, 2024Related Party Transactions For The Half Year Ended 31.03.2024May 27, 2024
May 27, 2024Promotion Of Dr. Suresh Ramachandran As Deputy Managing DirectorMay 27, 2024
May 27, 2024Re-Appointment/Appointment Of Independent DirectorsMay 27, 2024
May 27, 2024Technical Indicators
RSI(14)
Neutral 62.84
ATR(14)
Less Volatile 17.04
STOCH(9,6)
Overbought 87.06
STOCH RSI(14)
Neutral 78.30
MACD(12,26)
Bullish 5.08
ADX(14)
Weak Trend 15.42
UO(9)
Bearish 66.32
ROC(12)
Uptrend And Accelerating 7.84
WillR(14)
Overbought -17.55
About Sumitomo Chemical
Sumitomo Chemical India Limited (SCIL) is a subsidiary of Sumitomo Chemical Company Limited, Japan, engaged in manufacturing and selling household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products. The company also produces technical grade pesticides and has indigenous R&D facilities. SCIL was incorporated in 2000 and became a public limited company in 2018. In 2019, it merged with Excel Crop Care Limited, acquiring subsidiaries in Tanzania and Belgium. SCIL's shares were listed on BSE Limited and the National Stock Exchange of India Limited in 2020. The company has expanded its manufacturing capacity, introduced new products, and commissioned a solar power plant for captive consumption. As of 2021, the promoters and promoter group hold 75% of the company's share capital, with 25% held by the public.
Website
Chairperson NameMukul G Asher
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
